Technology | 2020.12.08
Hackensack Meridian Health and Visikol Partner to Evaluate Tuberculosis Treatments Using Visikol's Multiplex Imaging Tools
Visikol, a leader in advanced imaging, 3D cell-culture and digital pathology, is now leveraging its multiplex imaging tools to further drug discovery studies. Using the company’s proprietary multiplex imaging approach, Visikol will evaluate the ability of Tuberculosis treatments to reach the site of infection. This technology provides researchers with the ability to visualize many biomarkers within a single piece of tissue such that complex research questions can be addressed.
(PRWeb December 08, 2020)
Read the full story at https://www.prweb.com/releases/hackensack_meridian_health_and_visikol_partner_to_evaluate_tuberculosis_treatments_using_visikol_s_multiplex_imaging_tools/prweb17585218.htm
For more information, please visit
https://www.prweb.com/releases/hackensac[...]maging_tools/prweb17585218.htm
